ERDF — INSERM — Support to research projects — Project “Immunotherapy targeting tPA/NMDA receptor interaction for the treatment of central nervous system pathologies” (Invest) (Q3673447): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in fr, en, de, et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv, nl, it, es, and other parts: Adding translations: et, lt, it, fr, hr, el, en, sk, fi, pl, hu, nl, cs, lv, ga, sl, es, bg, mt, pt, da, ro, de, sv,) |
(Changed label, description and/or aliases in en, fr: Fixing missing labels.) |
||
| label / fr | label / fr | ||
FEDER - INSERM - Soutien aux projets de recherche - Projet "Immunothérapie ciblant l'interaction tPA/récepteur NMDA pour le traitement des pathologies du système nerveux central" (Invest) | |||
| label / en | label / en | ||
ERDF — INSERM — Support to research projects — Project “Immunotherapy targeting tPA/NMDA receptor interaction for the treatment of central nervous system pathologies” (Invest) | |||
Revision as of 10:21, 23 August 2022
Project Q3673447 in France
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | ERDF — INSERM — Support to research projects — Project “Immunotherapy targeting tPA/NMDA receptor interaction for the treatment of central nervous system pathologies” (Invest) |
Project Q3673447 in France |
Statements
23,500.00 Euro
0 references
47,000.0 Euro
0 references
50.0 percent
0 references
1 September 2014
0 references
28 February 2019
0 references
EPA INSERM INSTITUT NAT DE LA SANTE ET DE LA RECHERCHE MEDICALE
0 references
75654
0 references
Identifiers
15P05051
0 references